Genetic proxies for clinical traits are associated with increased risk of severe COVID-19

Abstract Routine use of genetic data in healthcare is much-discussed, yet little is known about its performance in epidemiological models including traditional risk factors. Using severe COVID-19 as an exemplar, we explore the integration of polygenic risk scores (PRS) into disease models alongside...

Full description

Saved in:
Bibliographic Details
Main Authors: N. J. M. Chaddock, S. S. R. Crossfield, M. Pujades-Rodriguez, M. M. Iles, A. W. Morgan
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-86260-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594715657109504
author N. J. M. Chaddock
S. S. R. Crossfield
M. Pujades-Rodriguez
M. M. Iles
A. W. Morgan
author_facet N. J. M. Chaddock
S. S. R. Crossfield
M. Pujades-Rodriguez
M. M. Iles
A. W. Morgan
author_sort N. J. M. Chaddock
collection DOAJ
description Abstract Routine use of genetic data in healthcare is much-discussed, yet little is known about its performance in epidemiological models including traditional risk factors. Using severe COVID-19 as an exemplar, we explore the integration of polygenic risk scores (PRS) into disease models alongside sociodemographic and clinical variables. PRS were optimized for 23 clinical variables and related traits previously-associated with severe COVID-19 in up to 450,449 UK Biobank participants, and tested in 9,560 individuals diagnosed in the pre-vaccination era. Associations were further adjusted for (i) sociodemographic and (ii) clinical variables. Pathway analyses of PRS were performed to improve biological understanding of disease. In univariate analyses, 17 PRS were associated with increased risk of severe COVID-19 and, of these, four remained associated with COVID-19 outcomes following adjustment for sociodemographic/clinical variables: hypertension PRS (OR = 1.1, 95%CI 1.03–1.18), atrial fibrillation PRS (OR = 1.12, 95%CI 1.03–1.22), peripheral vascular disease PRS (OR = 0.9, 95%CI 0.82–0.99), and Alzheimer’s disease PRS (OR = 1.14, 95%CI 1.05–1.25). Pathway analyses revealed enrichment of genetic variants in pathways for cardiac muscle contraction (genes N = 5; beta[SE] = 3.48[0.60]; adjusted-P = 1.86 × 10−5). These findings underscore the potential for integrating genetic data into epidemiological models and highlight the advantages of utilizing multiple trait PRS rather than a single PRS for a specific outcome of interest.
format Article
id doaj-art-b817e524da904b2bb77afa4525b07f6a
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-b817e524da904b2bb77afa4525b07f6a2025-01-19T12:23:28ZengNature PortfolioScientific Reports2045-23222025-01-0115111310.1038/s41598-025-86260-zGenetic proxies for clinical traits are associated with increased risk of severe COVID-19N. J. M. Chaddock0S. S. R. Crossfield1M. Pujades-Rodriguez2M. M. Iles3A. W. Morgan4University of Leeds (School of Medicine and Leeds Institute for Data Analytics)University of Leeds (School of Medicine and Leeds Institute for Data Analytics)University of Leeds (School of Medicine and Leeds Institute for Data Analytics)University of Leeds (School of Medicine and Leeds Institute for Data Analytics)University of Leeds (School of Medicine and Leeds Institute for Data Analytics)Abstract Routine use of genetic data in healthcare is much-discussed, yet little is known about its performance in epidemiological models including traditional risk factors. Using severe COVID-19 as an exemplar, we explore the integration of polygenic risk scores (PRS) into disease models alongside sociodemographic and clinical variables. PRS were optimized for 23 clinical variables and related traits previously-associated with severe COVID-19 in up to 450,449 UK Biobank participants, and tested in 9,560 individuals diagnosed in the pre-vaccination era. Associations were further adjusted for (i) sociodemographic and (ii) clinical variables. Pathway analyses of PRS were performed to improve biological understanding of disease. In univariate analyses, 17 PRS were associated with increased risk of severe COVID-19 and, of these, four remained associated with COVID-19 outcomes following adjustment for sociodemographic/clinical variables: hypertension PRS (OR = 1.1, 95%CI 1.03–1.18), atrial fibrillation PRS (OR = 1.12, 95%CI 1.03–1.22), peripheral vascular disease PRS (OR = 0.9, 95%CI 0.82–0.99), and Alzheimer’s disease PRS (OR = 1.14, 95%CI 1.05–1.25). Pathway analyses revealed enrichment of genetic variants in pathways for cardiac muscle contraction (genes N = 5; beta[SE] = 3.48[0.60]; adjusted-P = 1.86 × 10−5). These findings underscore the potential for integrating genetic data into epidemiological models and highlight the advantages of utilizing multiple trait PRS rather than a single PRS for a specific outcome of interest.https://doi.org/10.1038/s41598-025-86260-z
spellingShingle N. J. M. Chaddock
S. S. R. Crossfield
M. Pujades-Rodriguez
M. M. Iles
A. W. Morgan
Genetic proxies for clinical traits are associated with increased risk of severe COVID-19
Scientific Reports
title Genetic proxies for clinical traits are associated with increased risk of severe COVID-19
title_full Genetic proxies for clinical traits are associated with increased risk of severe COVID-19
title_fullStr Genetic proxies for clinical traits are associated with increased risk of severe COVID-19
title_full_unstemmed Genetic proxies for clinical traits are associated with increased risk of severe COVID-19
title_short Genetic proxies for clinical traits are associated with increased risk of severe COVID-19
title_sort genetic proxies for clinical traits are associated with increased risk of severe covid 19
url https://doi.org/10.1038/s41598-025-86260-z
work_keys_str_mv AT njmchaddock geneticproxiesforclinicaltraitsareassociatedwithincreasedriskofseverecovid19
AT ssrcrossfield geneticproxiesforclinicaltraitsareassociatedwithincreasedriskofseverecovid19
AT mpujadesrodriguez geneticproxiesforclinicaltraitsareassociatedwithincreasedriskofseverecovid19
AT mmiles geneticproxiesforclinicaltraitsareassociatedwithincreasedriskofseverecovid19
AT awmorgan geneticproxiesforclinicaltraitsareassociatedwithincreasedriskofseverecovid19